212 related articles for article (PubMed ID: 34506008)
21. Microscopically positive resection margin after hepatoblastoma resection: what is the impact on prognosis? A Childhood Liver Tumours Strategy Group (SIOPEL) report.
Aronson DC; Weeda VB; Maibach R; Czauderna P; Dall'Igna P; de Ville de Goyet J; Branchereau S; Perilongo G; Brock P; Zsiros J; Semeraro M; Chardot C; Wildhaber B; Morland B; Brugières L;
Eur J Cancer; 2019 Jan; 106():126-132. PubMed ID: 30528797
[TBL] [Abstract][Full Text] [Related]
22. Relapses in hepatoblastoma patients: clinical characteristics and outcome--experience of the International Childhood Liver Tumour Strategy Group (SIOPEL).
Semeraro M; Branchereau S; Maibach R; Zsiros J; Casanova M; Brock P; Domerg C; Aronson DC; Zimmermann A; Laithier V; Childs M; Roebuck D; Perilongo G; Czauderna P; Brugieres L
Eur J Cancer; 2013 Mar; 49(4):915-22. PubMed ID: 23146961
[TBL] [Abstract][Full Text] [Related]
23. Cisplatin, doxorubicin, and delayed surgery for childhood hepatoblastoma: a successful approach--results of the first prospective study of the International Society of Pediatric Oncology.
Pritchard J; Brown J; Shafford E; Perilongo G; Brock P; Dicks-Mireaux C; Keeling J; Phillips A; Vos A; Plaschkes J
J Clin Oncol; 2000 Nov; 18(22):3819-28. PubMed ID: 11078495
[TBL] [Abstract][Full Text] [Related]
24. Determinants of ototoxicity in 451 platinum-treated Dutch survivors of childhood cancer: A DCOG late-effects study.
Clemens E; de Vries AC; Pluijm SF; Am Zehnhoff-Dinnesen A; Tissing WJ; Loonen JJ; van Dulmen-den Broeder E; Bresters D; Versluys B; Kremer LC; van der Pal HJ; van Grotel M; van den Heuvel-Eibrink MM;
Eur J Cancer; 2016 Dec; 69():77-85. PubMed ID: 27821322
[TBL] [Abstract][Full Text] [Related]
25. Intensified platinum therapy is an ineffective strategy for improving outcome in pediatric patients with advanced hepatoblastoma.
Malogolowkin MH; Katzenstein H; Krailo MD; Chen Z; Bowman L; Reynolds M; Finegold M; Greffe B; Rowland J; Newman K; Womer RB; London WB; Castleberry RP
J Clin Oncol; 2006 Jun; 24(18):2879-84. PubMed ID: 16782927
[TBL] [Abstract][Full Text] [Related]
26. Health Status in Long-Term Survivors of Hepatoblastoma.
Dembowska-Bagińska B; Więckowska J; Brożyna A; Święszkowska E; Ismail H; Broniszczak-Czyszek D; Stefanowicz M; Grajkowska W; Kaliciński P
Cancers (Basel); 2019 Nov; 11(11):. PubMed ID: 31718024
[TBL] [Abstract][Full Text] [Related]
27. Hepatoblastoma presenting with lung metastases: treatment results of the first cooperative, prospective study of the International Society of Paediatric Oncology on childhood liver tumors.
Perilongo G; Brown J; Shafford E; Brock P; De Camargo B; Keeling JW; Vos A; Philips A; Pritchard J; Plaschkes J
Cancer; 2000 Oct; 89(8):1845-53. PubMed ID: 11042582
[TBL] [Abstract][Full Text] [Related]
28. Outcome of hepatoblastoma treated with the JPLT-1 (Japanese Study Group for Pediatric Liver Tumor) Protocol-1: A report from the Japanese Study Group for Pediatric Liver Tumor.
Sasaki F; Matsunaga T; Iwafuchi M; Hayashi Y; Ohkawa H; Ohira M; Okamatsu T; Sugito T; Tsuchida Y; Toyosaka A; Nagahara N; Nishihira H; Hata Y; Uchino J; Misugi K; Ohnuma N;
J Pediatr Surg; 2002 Jun; 37(6):851-6. PubMed ID: 12037748
[TBL] [Abstract][Full Text] [Related]
29. Hepatoblastoma throughout SIOPEL trials - clinical lessons learnt.
Czauderna P
Front Biosci (Elite Ed); 2012 Jan; 4(1):470-9. PubMed ID: 22201887
[TBL] [Abstract][Full Text] [Related]
30. Pantoprazole, an Inhibitor of the Organic Cation Transporter 2, Does Not Ameliorate Cisplatin-Related Ototoxicity or Nephrotoxicity in Children and Adolescents with Newly Diagnosed Osteosarcoma Treated with Methotrexate, Doxorubicin, and Cisplatin.
Fox E; Levin K; Zhu Y; Segers B; Balamuth N; Womer R; Bagatell R; Balis F
Oncologist; 2018 Jul; 23(7):762-e79. PubMed ID: 29445029
[TBL] [Abstract][Full Text] [Related]
31. [Outcome of hepatoblastoma: experience with 63 patients received chemotherapy with the regimen C5V].
Liu G; Liu B; Li K; Dong K; Xiao X
Zhonghua Er Ke Za Zhi; 2015 Feb; 53(2):119-23. PubMed ID: 25876687
[TBL] [Abstract][Full Text] [Related]
32. Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancer.
van Dalen EC; Raphaël MF; Caron HN; Kremer LC
Cochrane Database Syst Rev; 2014 Sep; (9):CD006647. PubMed ID: 25188452
[TBL] [Abstract][Full Text] [Related]
33. Improved survival outcome for hepatoblastoma based on an optimal chemotherapeutic regimen--a report from the study group for pediatric solid malignant tumors in the Kyushu area.
Suita S; Tajiri T; Takamatsu H; Mizote H; Nagasaki A; Inomata Y; Hara T; Okamura J; Miyazaki S; Kawakami K; Eguchi H; Tsuneyoshi M;
J Pediatr Surg; 2004 Feb; 39(2):195-8; discussion 195-8. PubMed ID: 14966739
[TBL] [Abstract][Full Text] [Related]
34. Current chemotherapeutic approaches for hepatoblastoma.
Watanabe K
Int J Clin Oncol; 2013 Dec; 18(6):955-61. PubMed ID: 24052132
[TBL] [Abstract][Full Text] [Related]
35. Outcome and Late Complications of Hepatoblastomas Treated Using the Japanese Study Group for Pediatric Liver Tumor 2 Protocol.
Hiyama E; Hishiki T; Watanabe K; Ida K; Ueda Y; Kurihara S; Yano M; Hoshino K; Yokoi A; Takama Y; Nogami Y; Taguchi T; Mori M; Kihira K; Miyazaki O; Fuji H; Honda S; Iehara T; Kazama T; Fujimura J; Tanaka Y; Inoue T; Tajiri T; Kondo S; Oue T; Yoshimura K
J Clin Oncol; 2020 Aug; 38(22):2488-2498. PubMed ID: 32421442
[TBL] [Abstract][Full Text] [Related]
36. Fibrolamellar variant of hepatocellular carcinoma does not have a better survival than conventional hepatocellular carcinoma--results and treatment recommendations from the Childhood Liver Tumour Strategy Group (SIOPEL) experience.
Weeda VB; Murawski M; McCabe AJ; Maibach R; Brugières L; Roebuck D; Fabre M; Zimmermann A; Otte JB; Sullivan M; Perilongo G; Childs M; Brock P; Zsíros J; Plaschkes J; Czauderna P; Aronson DC
Eur J Cancer; 2013 Aug; 49(12):2698-704. PubMed ID: 23683550
[TBL] [Abstract][Full Text] [Related]
37. Hepatoblastoma in children aged less than six months at diagnosis: A report from the SIOPEL group.
Dall'Igna P; Brugieres L; Christin AS; Maibach R; Casanova M; Alaggio R; de Goyet JV; Zsiros J; Morland B; Czauderna P; Childs M; Aronson DC; Branchereau S; Brock P; Perilongo G
Pediatr Blood Cancer; 2018 Jan; 65(1):. PubMed ID: 28921839
[TBL] [Abstract][Full Text] [Related]
38. A trend of improved survival of childhood hepatoblastoma treated with cisplatin and doxorubicin in Taiwanese children.
Chiu SN; Ni YH; Lu MY; Lin DT; Lin KH; Lai HS; Chang MH
Pediatr Surg Int; 2003 Oct; 19(8):593-7. PubMed ID: 14556026
[TBL] [Abstract][Full Text] [Related]
39. Treatment outcome and pattern of failure in hepatoblastoma treated with a consensus protocol in Hong Kong.
Liu APY; Ip JJK; Leung AWK; Luk CW; Li CH; Ho KKH; Lo R; Chan EKW; Chan ACY; Chung PHY; Chiang AKS
Pediatr Blood Cancer; 2019 Jan; 66(1):e27482. PubMed ID: 30270490
[TBL] [Abstract][Full Text] [Related]
40. Initial liver transplantation for unresectable hepatoblastoma after chemotherapy.
Héry G; Franchi-Abella S; Habes D; Brugières L; Martelli H; Fabre M; Pariente D; Gauthier F; Jacquemin E; Branchereau S
Pediatr Blood Cancer; 2011 Dec; 57(7):1270-5. PubMed ID: 21910210
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]